Form D · Biotechnology
Reshape Medical, Inc.
San Clemente, CA · CIK 0001410930
Offering snapshot reported Feb 13, 2017 · SEC filing
- Reported sold
- $11M Offering amount: $11M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 31, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 13, 2017 | Initial | $11,000,000 | No comparison | 10 | SEC filing |
| Sep 2, 2015 | Initial | $37,999,991 | No comparison | 10 | SEC filing |
| Mar 19, 2015 | Amendment | $8,750,000 | $4,750,000vs Jul 8, 2014 | 7 | SEC filing |
| Feb 4, 2015 | Amendment | $6,750,000 | $2,750,000vs Jul 8, 2014 | 7 | SEC filing |
| Dec 11, 2014 | Amendment | $5,250,000 | $1,250,000vs Jul 8, 2014 | 7 | SEC filing |
| Jul 8, 2014 | Initial | $4,000,000 | No comparison | 7 | SEC filing |
| Oct 19, 2012 | Initial | $15,822,657 | No comparison | 7 | SEC filing |
| Jun 6, 2012 | Initial | $1,500,000 | No comparison | 7 | SEC filing |
| Oct 29, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 24, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-280573
Source: Form D, filed Feb 13, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Adox | Director |
| Kent Charhut | Director |
| Kenneth Charhut | Director |
| Jeani Delagardelle | Director |
| Bruce Feuchter | Executive |
| Robert Grant | Director |
| John Lehmann, M.D. | Director |
| Michael Mangano | Director, Executive |
| Michael Mashaal | Director |
| Eric Milledge | Director |
| David Milne | Director |
| Casey Tansey | Director |
| Richard Thompson | Director, Executive |
| George Wallace | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
236 Avenida Fabricante
San Clemente, CA, 92672
San Clemente, CA, 92672